Molecular Screening of PAX2 Gene Polymorphism in Primary Vesicoureteral Reflux Patients in Taif Governorate, KSA

2021 ◽  
Vol 24 (4) ◽  
pp. 492-499
Author(s):  
Ehab I. El-Hall ◽  
Abdulla A. Alharthi ◽  
Ahmed Gaber ◽  
Mohamed M. Hassan
Keyword(s):  
Gene Polymorphism ◽  
Vesicoureteral Reflux ◽  
Molecular Screening ◽  
Primary Vesicoureteral Reflux ◽  
Pax2 Gene

Angiotensin converting enzyme gene polymorphism in primary vesicoureteral reflux

2001 ◽  
Vol 16 (8) ◽  
pp. 648-652 ◽  
Author(s):  
Yoshiyuki Ohtomo ◽  
Rieko Nagaoka ◽  
Kazunari Kaneko ◽  
Yutaka Fukuda ◽  
Takeshi Miyano ◽  
...  
Keyword(s):  
Gene Polymorphism ◽  
Angiotensin Converting Enzyme ◽  
Vesicoureteral Reflux ◽  
Angiotensin Converting Enzyme Gene ◽  
Converting Enzyme ◽  
Enzyme Gene ◽  
Primary Vesicoureteral Reflux

Medical Versus Surgical Treatment of Primary Vesicoureteral Reflux

PEDIATRICS ◽  
1981 ◽  
Vol 67 (3) ◽  
pp. 392-400 ◽  
Keyword(s):  
Surgical Treatment ◽  
Vesicoureteral Reflux ◽  
Therapeutic Intervention ◽  
Renal Damage ◽  
Rational Basis ◽  
Benefit Ratio ◽  
International Trial ◽  
Prospective Longitudinal ◽  
Primary Vesicoureteral Reflux

The role of VUR in the development and progression of renal damage in children is universally acknowledged. The risk/benefit ratio of therapeutic intervention, whether medical or surgical, continues to be debated. This carefully controlled prospective, longitudinal, multispecialty, international trial aims to establish a rational basis for the treatment of VUR.

Risk of hypertension in primary vesicoureteral reflux

2007 ◽  
Vol 22 (3) ◽  
pp. 459-462 ◽  
Author(s):  
Ana C. Simoes e Silva ◽  
Jose Maria P. Silva ◽  
Jose Silverio S. Diniz ◽  
Sérgio V. B. Pinheiro ◽  
Eleonora M. Lima ◽  
...  
Keyword(s):  
Vesicoureteral Reflux ◽  
Primary Vesicoureteral Reflux
Sign in / Sign up

Export Citation Format

Share Document